(Total Views: 42)
Posted On: 09/28/2020 8:25:51 AM
Post# of 35809

$CATB News Article - Catabasis Pharmaceuticals Presents Information on Edasalonexent, a Potential Foundational Therapy for Duchenne Muscular Dystrophy, at the Virtual 25th International Congress of the World Muscle Society https://marketwirenews.com/news-releases/cata...39564.html


My Twitter: WhyteStocks